Stephen Zarrilli's Trading History
| GMEDGlobus Medical | Aug 19, 2026 | Director | Uninformative Buy | 1.33M | $0.00 | |
| VRTSVirtus Investment Partners | Mar 07, 2024 | Director | Informative Sell | 534.04K | $419.60K | |
| SFESSafeguard Scientifics | Jun 18, 2018 | President & CEO, Director | Uninformative Sell | 14.54K | $101.50K | |
| DPGDuff & Phelps Utility and Infrastructure Fund Inc | May 22, 2017 | Director | Uninformative Buy | 101.21K | $29.34K | |
| NTRINutrisystem Inc | May 14, 2015 | ― | Uninformative Buy | ― | $600.25K |
You May Also Like
Stephen Zarrilli insider profile FAQ
What is the percentage of profitable transactions made by Stephen Zarrilli?
The percentage of profitable transactions made by Stephen Zarrilli is 42%.
What is the average return per transaction made by Stephen Zarrilli?
The average return per transaction made by Stephen Zarrilli is -10.50%.
What stocks does Stephen Zarrilli hold?
Stephen Zarrilli holds: GMED, DPG, SFES, NTRI, VRTS stocks.
What was Stephen Zarrilli’s latest transaction?
Stephen Zarrilli’s latest transaction was an Uninformative Buy of $1.33M.
What was Stephen Zarrilli's most profitable transaction?
Stephen Zarrilli’s most profitable transaction was an Informative Sell of VRTS stock on August 5, 2021. The return on the trade was 31.90%.
What is Stephen Zarrilli's role in Globus Medical?
Stephen Zarrilli's role in Globus Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.